Literature DB >> 27928375

A Randomised Controlled Trial of Treatment for Post-Stroke Homonymous Hemianopia: Screening and Recruitment.

Fiona J Rowe1, Elizabeth J Conroy2, P Graham Barton3, Emma Bedson4, Emma Cwiklinski4, Caroline Dodridge5, Avril Drummond6, Marta Garcia-Finana2, Claire Howard7, Stevie Johnson8, Claire MacIntosh5, Carmel P Noonan9, Alex Pollock10, Janet Rockliffe11, Catherine M Sackley12, Tracey Shipman13.   

Abstract

The authors report the screening process and recruitment figures for the VISION (Visual Impairment in Stroke; Intervention Or Not) trial. This is a prospective, randomised, single-blinded, three-arm controlled trial in 14 UK acute hospital stroke units. Stroke teams identified stroke survivors suspected as having homonymous hemianopia. Interventions included Fresnel prisms versus visual search training versus standard care (information only). Primary outcome was change in visual field assessment from baseline to 26 weeks. Secondary measures included change in quality-of-life questionnaires. Recruitment opened in May 2011. A total of 1171 patients were screened by the local principal investigators. Of 1171 patients, 178 (15.2%) were eligible for recruitment: 87 patients (7.4%) provided consent and were recruited; 91 patients (7.8%) did not provide consent, and 993 of 1171 patients (84.8%) failed to meet the eligibility criteria. Almost half were excluded due to complete/partial recovery of hemianopia (43.6%; n = 511). The most common ineligibility reason was recovery of hemianopia. When designing future trials in this area, changes in eligibility criteria/outcome selection to allow more patients to be recruited should be considered, e.g., less stringent levels of visual acuity/refractive error. Alternative outcomes measurable in the home environment, rather than requiring hospital attendance for follow-up, could facilitate increased recruitment.

Entities:  

Keywords:  Fresnel prisms; homonymous hemianopia; randomised controlled trial; recruitment; screening; stroke; visual search

Year:  2016        PMID: 27928375      PMCID: PMC5123152          DOI: 10.3109/01658107.2015.1126288

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  19 in total

1.  Homonymous hemianopias: clinical-anatomic correlations in 904 cases.

Authors:  X Zhang; S Kedar; M J Lynn; N J Newman; V Biousse
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

Review 2.  Strategies to improve recruitment to randomised controlled trials.

Authors:  Shaun Treweek; Marie Pitkethly; Jonathan Cook; Monica Kjeldstrøm; Taina Taskila; Marit Johansen; Frank Sullivan; Sue Wilson; Catherine Jackson; Ritu Jones; Elizabeth Mitchell
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

3.  Symptoms and signs of posterior circulation ischemia in the new England medical center posterior circulation registry.

Authors:  D Eric Searls; Ladislav Pazdera; Evzen Korbel; Oldrich Vysata; Louis R Caplan
Journal:  Arch Neurol       Date:  2011-11-14

Review 4.  Interventions for visual field defects in patients with stroke.

Authors:  Alex Pollock; Christine Hazelton; Clair A Henderson; Jayne Angilley; Baljean Dhillon; Peter Langhorne; Katrina Livingstone; Frank A Munro; Heather Orr; Fiona J Rowe; Uma Shahani
Journal:  Cochrane Database Syst Rev       Date:  2011-10-05

5.  Posterior versus anterior circulation infarction: how different are the neurological deficits?

Authors:  Wen-Dan Tao; Ming Liu; Marc Fisher; De-Ren Wang; Jie Li; Karen L Furie; Zi-Long Hao; Sen Lin; Can-Fei Zhang; Quan-Tao Zeng; Bo Wu
Journal:  Stroke       Date:  2012-06-07       Impact factor: 7.914

6.  Functional assessment scales: a study of persons after stroke.

Authors:  C V Granger; A C Cotter; B B Hamilton; R C Fiedler
Journal:  Arch Phys Med Rehabil       Date:  1993-02       Impact factor: 3.966

7.  What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies.

Authors:  Alison M McDonald; Rosemary C Knight; Marion K Campbell; Vikki A Entwistle; Adrian M Grant; Jonathan A Cook; Diana R Elbourne; David Francis; Jo Garcia; Ian Roberts; Claire Snowdon
Journal:  Trials       Date:  2006-04-07       Impact factor: 2.279

8.  Recovery of visual fields in brain-lesioned patients by reaction perimetry treatment.

Authors:  Fritz Schmielau; Edward K Wong
Journal:  J Neuroeng Rehabil       Date:  2007-08-16       Impact factor: 4.262

9.  Developing a survey of barriers and facilitators to recruitment in randomized controlled trials.

Authors:  Geetinder Kaur; Rosalind L Smyth; Paula Williamson
Journal:  Trials       Date:  2012-11-21       Impact factor: 2.279

10.  A randomised controlled trial to compare the clinical and cost-effectiveness of prism glasses, visual search training and standard care in patients with hemianopia following stroke: a protocol.

Authors:  F J Rowe; P G Barton; E Bedson; R Breen; E J Conroy; E Cwiklinski; C Dodridge; A Drummond; M Garcia-Finana; C Howard; S Johnson; C MacIntosh; C P Noonan; A Pollock; J Rockliffe; C Sackley; T Shipman
Journal:  BMJ Open       Date:  2014-07-17       Impact factor: 2.692

View more
  3 in total

1.  Interventions for visual field defects in people with stroke.

Authors:  Alex Pollock; Christine Hazelton; Fiona J Rowe; Sven Jonuscheit; Ashleigh Kernohan; Jayne Angilley; Clair A Henderson; Peter Langhorne; Pauline Campbell
Journal:  Cochrane Database Syst Rev       Date:  2019-05-23

2.  Visual Function Questionnaire as an outcome measure for homonymous hemianopia: subscales and supplementary questions, analysis from the VISION trial.

Authors:  Fiona J Rowe; Lauren R Hepworth; Elizabeth J Conroy; Naomi E A Rainford; Emma Bedson; Avril Drummond; Marta García-Fiñana; Claire Howard; Alex Pollock; Tracey Shipman; Caroline Dodridge; Stevie Johnson; Carmel Noonan; Catherine Sackley
Journal:  Eye (Lond)       Date:  2019-04-17       Impact factor: 3.775

3.  Low vision rehabilitation for better quality of life in visually impaired adults.

Authors:  Ruth Ma van Nispen; Gianni Virgili; Mirke Hoeben; Maaike Langelaan; Jeroen Klevering; Jan Ee Keunen; Ger Hmb van Rens
Journal:  Cochrane Database Syst Rev       Date:  2020-01-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.